Mycoplasma pneumoniae infection
Conditions
Interventions
F1 group: MP mixed infection group.:Internal and external treatment of traditional Chinese medicine+intravenous drip of macrolide antibiotics+atomization treatment
Group D: MP negative group:Internal and external treatment of traditional Chinese medicine+intravenous drip of macrolide antibiotics+atomization treatment
Group e: MRMP group
Group f: MSMP group:Internal and external treatment of traditional Chinese medicine+intravenous drip of macrolide antibiotics+atomization treatment
E1 group: MP simple infection group
Group B: Chinese patent medicine combined with basic treatment.
Group C: MP positive group
Group A: qingrun group
Group B: Chinese patent medicine group:Group A: TCM decoction therapy combined with basic therapy
Sponsors
The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
No minimum to 14 Years
Inclusion criteria
Inclusion criteria: 1) MP infected patients in the pediatric ward of the Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine from February 2023 to January 2024; 2) Meet the diagnostic criteria of traditional Chinese medicine; 3) The diagnosis conforms to the Guidelines for Diagnosis and Treatment of Mycoplasma Pneumonia in Children (2023 Edition); 4) Age =14 years; 5) The clinical data is complete.
Exclusion criteria
Exclusion criteria: 1) Patients with other immune diseases and/or using immunomodulators; 2) Combined with other infectious diseases; 3) Patients with congenital organ dysfunction and hematopoietic dysfunction; 4) Patients with serious complications such as heart failure, respiratory failure and hypoxic encephalopathy; 5) Patients with missing clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| General information;Time for symptoms and signs to subside;Laboratory indicators;Imaging examination (X-ray or CT);Total effective rate of disease;Therapeutic effect of TCM symptoms;Follow-up index: incidence of respiratory diseases; | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection of respiratory pathogens and drug resistance genes; | — |
Countries
China
Contacts
Public ContactWu Zhen-qi
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, No.33 Beiling Street, Huanggu District, Shenyang
Outcome results
None listed